<?xml version="1.0" encoding="UTF-8"?>
<ref id="B365">
 <label>365.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Ojha</surname>
    <given-names>R</given-names>
   </name>, 
   <name name-style="western">
    <surname>Gupta</surname>
    <given-names>N</given-names>
   </name>, 
   <name name-style="western">
    <surname>Naik</surname>
    <given-names>B</given-names>
   </name>, 
   <name name-style="western">
    <surname>Singh</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Verma</surname>
    <given-names>VK</given-names>
   </name>, 
   <name name-style="western">
    <surname>Prusty</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Prajapati</surname>
    <given-names>VK</given-names>
   </name>
  </person-group>
  <day>14</day>
  <month>5</month>
  <year>2020</year>
  <article-title>High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19</article-title>. 
  <source>Eur J Pharm Sci</source> doi:
  <pub-id pub-id-type="doi">10.1016/j.ejps.2020.105375</pub-id>.
 </mixed-citation>
</ref>
